ClinicalTrials.Veeva

Menu

Unilateral TAP Block vs Trocar Insertion Sites Infiltration Anesthesia in Laparoscopic Cholecystectomy

D

Diskapi Yildirim Beyazit Training and Research Hospital

Status

Completed

Conditions

Biliary Disease

Treatments

Drug: Intravenous patient controlled analgesia
Drug: Transversus abdominis plane block
Drug: local infiltration anesthesia

Study type

Interventional

Funder types

Other

Identifiers

NCT03543202
EmineTAP

Details and patient eligibility

About

Laparoscopic cholecystectomy is a commonly performed operation in general surgery practice. Peripheral nerve block methods commonly used for analgesia after this operation are: transversus abdominis plane block (TAP) and trocar insertion sites local anesthetic infiltration anesthesia In this study, we aimed to compare these methods in terms of postoperative analgesia, nausea-vomiting and patient satisfaction

Full description

Patients will be randomly allocated by a computer generated random numbers list into three groups. After general anesthesia induction and intubation patients will receive analgesia according to group allocation. In group TAP (Group T) the transversus abdominis plane block will be commenced with ultrasound guidance while the patients is in the supine position with a subcostal approach using 20 mL 0.25% bupivacaine and 21 G block needle. In group infiltration anesthesia (Group I) the trocar insertion sites will be infiltrated with 20 mL 0.25% bupivacaine: 7 mL for the 10 mm trocar insertion sites and 3 mL for the 5 mm trocar insertion sites. The control group (Group C) will not receive any local anesthetic. All patients will receive rescue analgesia with intravenous patient controlled analgesia with tramadol (20 mg bolus dose and 20 minutes lockout time)

Postoperative pain will be assessed during resting and coughing with a Numeric Pain Scale (NRS) and nausea and vomiting with a Postoperative Nausea Vomiting Score at the postoperative 1, 3, 6, 12. and 24 hours. The amount of tramadol consumed in the postoperative period will be recorded. Patient satisfaction will be assessed with the Likert scale at postoperative 24 hours.

Enrollment

72 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of biliary disease

Exclusion criteria

  • Uncooperative patients
  • Blood coagulation disorders
  • Laparatomy
  • Obesity: body mass index >35
  • Renal failure
  • Hepatic failure
  • Emergency surgery
  • Pregnancy

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

72 participants in 3 patient groups

Transversus abdominis plane block
Experimental group
Description:
will receive 20ml bupivacaine for Transversus abdominis plane block and intravenous patient controlled analgesia
Treatment:
Drug: Transversus abdominis plane block
Drug: Intravenous patient controlled analgesia
Local infiltration anesthesia
Active Comparator group
Description:
will receive 20ml bupivacaine for Local infiltration anesthesia and intravenous patient controlled analgesia
Treatment:
Drug: local infiltration anesthesia
Drug: Intravenous patient controlled analgesia
Intravenous patient control analgesia
Sham Comparator group
Description:
will not receive any regional anethetic intervention will receive intravenous patient controlled analgesia
Treatment:
Drug: Intravenous patient controlled analgesia

Trial contacts and locations

1

Loading...

Central trial contact

Emine Arik, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems